These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 392970)

  • 61. 0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effects.
    Kerscher MJ; Korting HC; Mehringer L; Mätzig R
    Skin Pharmacol; 1996; 9(2):120-3. PubMed ID: 8722606
    [TBL] [Abstract][Full Text] [Related]  

  • 62. double-blind"double-bind.
    Björnberg A; Hellgren L
    Curr Med Res Opin; 1975; 3(1):36-8. PubMed ID: 1090417
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Generalized pustular psoriasis associated with withdrawal of topical clobetasol-17-propionate.
    Telfer NR; Dawber RP
    J Am Acad Dermatol; 1987 Jul; 17(1):144-5. PubMed ID: 3611449
    [No Abstract]   [Full Text] [Related]  

  • 64. Treatment of chronic eczemas. The comparative efficacy of two creams.
    Doherty JC; MacRae KD; Platt NE
    Practitioner; 1979 Apr; 222(1330):561-3. PubMed ID: 382173
    [No Abstract]   [Full Text] [Related]  

  • 65. [Results of the use of diflorasone diacetate ointment in dermatology].
    Chiarenza A
    G Ital Dermatol Venereol; 1982; 117(3):XIX-XXII. PubMed ID: 6764908
    [No Abstract]   [Full Text] [Related]  

  • 66. Psoriasis treated with clobetasol propionate and photochemotherapy.
    Gould PW; Wilson L
    Br J Dermatol; 1978 Feb; 98(2):133-6. PubMed ID: 343806
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical experience with 0.05% clobetasol propionate creams.
    Richards RN
    J Am Acad Dermatol; 1985 May; 12(5 Pt 1):891-3. PubMed ID: 4008693
    [No Abstract]   [Full Text] [Related]  

  • 68. [Use of 0.3% diflucortolone valerate in the topical treatment of steroid-sensitive dermatitis].
    Jucci A; Fideli D; Speziali A
    G Ital Dermatol Venereol; 1986; 121(6):LXXVII-LXXX. PubMed ID: 3549546
    [No Abstract]   [Full Text] [Related]  

  • 69. Intermittent application of clobetasol-17-propionate in psoriasis.
    Young E; van der Velde EA
    Curr Med Res Opin; 1987; 10(7):468-73. PubMed ID: 3621992
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Systemic effects of topically applied clobetasone 17-butyrate ointment--comparative studies with hydrocortisone 17-butyrate ointment (author's transl)].
    Nihon Hifuka Gakkai Zasshi; 1980; 90(6):491-502. PubMed ID: 6967986
    [No Abstract]   [Full Text] [Related]  

  • 71. Clobetasol propionate for PUVA overdosage.
    Hindson C; Spiro J; Blyth B
    Br J Dermatol; 1984 May; 110(5):633. PubMed ID: 6722031
    [No Abstract]   [Full Text] [Related]  

  • 72. Treatment of nummular psoriasis with a clobetasol propionate stick.
    Bergstedt C; Gamborg Nielsen P; Karlsson L; Strömberg L
    Dermatology; 1992; 184(1):51-3. PubMed ID: 1558995
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The response of psoriasis to betamethasone valerate and clobetasol propionate. A 6-month controlled study.
    Corbett MF
    Br J Dermatol; 1976 Mar; 94 suppl 12():89-93. PubMed ID: 773414
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Preatrophy: covert sign of thinned skin.
    Katz HI; Prawer SE; Mooney JJ; Samson CR
    J Am Acad Dermatol; 1989 May; 20(5 Pt 1):731-5. PubMed ID: 2654214
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A clinical comparison of betamethasone 17,21-dipropionate and clobetasol propionate creams in dermatology.
    Voigtländer V
    J Int Med Res; 1977; 5(2):128-31. PubMed ID: 326594
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Investigation of the pharmacokinetics of clobetasol propionate and clobetasone butyrate after a single application of ointment.
    Hehir M; Du Vivier A; Eilon L; Danie MJ; Shenoy EV
    Clin Exp Dermatol; 1983 Mar; 8(2):143-51. PubMed ID: 6851236
    [No Abstract]   [Full Text] [Related]  

  • 77. A study of the comparative efficacy of diflucortolone valerate 0.3% ointment and clobetasol propionate 0.05% ointment.
    Wendt H; Mugglestone CJ; Wiseman RA
    Br J Dermatol; 1978 Oct; 99(4):411-6. PubMed ID: 361059
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Plasma cortisol values after topical application of diflucortolone valerate (0.3%) or clobetasol propionate (0.05%) in psoriatic patients.
    Keczkes K; Teasdale P; Wiseman RA; Mugglestone CJ
    Br J Dermatol; 1978 Oct; 99(4):417-20. PubMed ID: 361060
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multicenter trial of fluocinonide in an emollient cream base.
    Fisher M; Kelly AP
    Int J Dermatol; 1979 Oct; 18(8):660-4. PubMed ID: 389843
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Percutaneous absorption of clobetasol propionate from novel ointment and cream formulations.
    Harding SM; Sohail S; Busse MJ
    Clin Exp Dermatol; 1985 Jan; 10(1):13-21. PubMed ID: 3987081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.